BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

May 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-04-30

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-30	Common Stock	A	715	$29.69	Acquired	74565	Direct
2014-05-01	Common Stock	S	715	$59.6734	Disposed	73850	Direct

Footnotes

F1: The reporting person is reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2013 to April 30, 2014.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $57.50 to $60.82. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sod at each price within the range.